Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. E. Katelnikova"'
Autor:
K. L. Kryshen, A. A. Muzhikyan, D. S. Gaidai, K. O. Zaikin, A. E. Katelnikova, M. Yu. Samsonov, E. I. Mukhametshina, G. E. Konopleva, E. V. Shipaeva, A. A. Dmitrieva, F. S. Shagiakhmetov, A. O. Popova, M. N. Makarova, V. G. Makarov
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 6, Iss 2, Pp 58-68 (2019)
Opioid receptor antagonists are widely used for the treatment of alcohol dependence. Currently, original drug Odelepran (INN: ondelopran) with a unique binding profi le to all three types of human opioid receptors (μ, κ, δ) is being developed by
Externí odkaz:
https://doaj.org/article/cc97aa7303954c77ba50c93ca8d5605d
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 8, Iss 2, Pp 109-114 (2018)
The article describes theoretical foundations and successful experimental testing of a modified method of intravitreal injection (IVI) in the rabbit eye performed in the laboratory. The method needed modification because preoperative preparation desc
Externí odkaz:
https://doaj.org/article/0228f08a3b2e4bfa97f6058fb24eed7a
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 8, Iss 1, Pp 44-55 (2018)
The assessment of allergic risk at the preclinical stage of drug development has been a debatable issue due to the integration of national requirements for medicines authorisation with those of the Eurasian Economic Union (EAEU). The article summaris
Externí odkaz:
https://doaj.org/article/579291b6455f4b938226ce086eb7de35
Autor:
Sevastyan O. Rabdano, Ellina A. Ruzanova, Iuliia V. Pletyukhina, Nikita S. Saveliev, Kirill L. Kryshen, Anastasiia E. Katelnikova, Petr P. Beltyukov, Liliya N. Fakhretdinova, Ariana S. Safi, German O. Rudakov, Sergei A. Arakelov, Igor V. Andreev, Ilya A. Kofiadi, Musa R. Khaitov, Rudolf Valenta, Daria S. Kryuchko, Igor A. Berzin, Natalia S. Belozerova, Anatoly E. Evtushenko, Viktor P. Truhin, Veronika I. Skvortsova
Publikováno v:
Vaccines, Vol 11, Iss 4, p 874 (2023)
The vast majority of SARS-CoV-2 vaccines which are licensed or under development focus on the spike (S) protein and its receptor binding domain (RBD). However, the S protein shows considerable sequence variations among variants of concern. The aim of
Externí odkaz:
https://doaj.org/article/108008ddc4e641e78d6834ce0db95b43
Autor:
Arina D. Goshina, Victoria A. Matyushenko, Svetlana A. Donina, Ivan A. Sychev, Irina N. Isakova-Sivak, Anastasia E. Katelnikova, Larisa G. Rudenko
Publikováno v:
Medical academic journal. 2:157-162
BACKGROUND: Determination of serum antibody levels to the novel coronavirus SARS-CoV-2 is a necessary tool for assessing humoral immunity in COVID-19 patients or individuals vaccinated with specific vaccines, as well as for studying the immune respon
Publikováno v:
Medical academic journal. 21:127-130
The development of a universal influenza vaccine with a wide spectrum and duration of action is one of the serious public health problems. This study is dedicated to optimization of an immunogen covering the M2e epitopes of influenza A viruses circul
Autor:
Olga N. Pozharitskaya, Alexander N. Shikov, Valerii Gennad’evich Makarov, Anastasiya E. Katelnikova, Petr Dmitriyevich Shabanov, Victoria V. Vorobieva
Publikováno v:
Reviews on Clinical Pharmacology and Drug Therapy. 15:4-13
The data of possibilities to use biologically active compounds, peptides and polysaccharides in particular, from sea urchins as potent sources of drugs are represented in the article. Their ability to act on the main chains of pathogenesis of the res
Autor:
Anastasiya E. Katelnikova, Kirill L Kryishen, Victoria V. Vorobieva, Alexander N. Shikov, V. G. Makarov, Olga N. Pozharitskaya
Publikováno v:
Reviews on Clinical Pharmacology and Drug Therapy. 14:9-15
We performed the study of the anti-inflammatory activity of glycosylated polypeptide complex (GPC) extracted from sea urchins Strongylocentrotus droebachiensis in the model of acute bronchitis induced by endotracheal administration of 1% formalin sol